4-Bromo-2,5-dichloro-6-fluorobenzaldehyde, 250mg

6-Chloro-N'-hydroxynicotinimidamide, 95.0%, 1g

2,3,4,5,6-Pentaiodobenzoic acid, 98%, 100mg

4-Hydroxybenzohydrazide>98.0%(HPLC)100g

4-(Chlorophenyl)-4-hydroxypiperidine, 97.0%, 25g

2,6-Dimethylcyclohexanol (mixture of isomers)>99.0%(GC)25mL

1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyrrolo[2,3-c]pyridine, 95.0%, 500mg

4-Chloro-6-Fluoroindan-1-one, 95.0%, 1g

4-Bromo-7-methoxyquinoline, 95.0%, 25g

Diisopropyl L-(+)-Tartrate>98.0%(GC)500g

GC-Kapillarsäule ROTI®Cap-FFAP, 10 m, 0.10 mm, 0.10 µm, polar, 1 Stück

3,9-Divinyl-2,4,8,10-tetraoxaspiro[5.5]undecane>98.0%(GC)25g

N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine dihydrochloride, 98%, 5g